0.00
price down icon100.00%   -0.84
after-market Dopo l'orario di chiusura: .84 0.84 +
loading

Salarius Pharmaceuticals Inc Azioni (SLRX) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Revenues
-
- - - -
Operating Expenses
43.82%
0.9656
1.7187 1.4887 1.0065 1.4675
Operating Income/Loss
43.82%
-0.9656
-1.7187 -1.4887 -1.0065 -1.4675
Income/Loss From Continuing Operations Before Tax
43.97%
-0.9578
-1.7095 -1.4639 -0.9721 -1.4244
Income/Loss From Continuing Operations After Tax
43.97%
-0.9578
-1.7095 -1.4639 -0.9721 -1.4244
Net Income/Loss
43.97%
-0.9578
-1.7095 -1.4639 -0.9721 -1.4244
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
27.58%
2.1229
1.6639 0.1608 1.2819 0.6004
Diluted Average Shares
27.58%
2.1229
1.6639 0.1608 1.2819 0.6004
Basic Earnings Per Share
56.31%
-0.45
-1.03 -0.66 -0.76 -2.37
Diluted Earnings Per Share
56.31%
-0.45
-1.03 -0.66 -0.76 -2.37
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$33.63
price down icon 0.80%
$107.39
price up icon 4.56%
$105.92
price down icon 4.21%
$98.85
price down icon 1.23%
biotechnology ONC
$320.37
price down icon 4.04%
$170.27
price down icon 3.26%
Capitalizzazione:     |  Volume (24 ore):